Delivery Order SPE2DB24D2205-SPE2DB25FDXGN
Award Date
1/24/25
Potential Completion Date
1/27/25
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,341.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the supply of pharmaceutical products, including the QUVIVIQ 50 MG TABLET 30S, to support military healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,521.36 firm fixed-price delivery order is for the supply of the prescription medication QUVIVIQ 50 MG TABLET 30S. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,954.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of QUVIVIQ 25 MG TABLET 30S, a pharmaceutical product, and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the delivery of the pharmaceutical product QUVIVIQ 50 MG TABLET 30S to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The $1,112.65 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 10, 2024, with an ultimate completion date of September 11, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FUG75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,217.84, is a Firm Fixed Price Delivery Order for the supply of QUVIVIQ 25 MG TABLET 30S, a pharmaceutical product. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The award, valued at $1,324.19, is for the delivery of the prescription medication QUVIVIQ 25 MG TABLET 30S. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award, with ID SPE2DB22D2006|SPE2DB25FV7JY, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,682.54 fixed-price delivery order is for QUVIVIQ 25 MG TABLET 30S, a pharmaceutical product, with a period of performance through January 6, 2025. The award is not associated with a set-aside program. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,809.92 Firm Fixed Price Delivery Order is for the provision of the drug QUVIVIQ 25 MG TABLET 30S. The contract has an ultimate completion date of June 10, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of QUVIVIQ 50 MG TABLET 30S, a pharmaceutical product. The total potential value of the contract is $1,586.73, with a performance period from March 6, 2024 to March 7, 2024. This award is not associated with any set-aside designation. Amerisourcebergen Drug Corp, a for-profit organization,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,146.19 firm-fixed-price delivery order contract is for the provision of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The award has a completion date of July 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...